• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Arthur Allen

  • Robert F. Kennedy Jr.Health

    With RFK Jr. in charge, supplement makers see chance to cash in

    By KFF Health News and Arthur Allen
  • UNITED STATES – NOVEMBER 10: Dr. Jay Bhattacharya speaks during a roundtable discussion with members of the House Freedom Caucus on the COVID-19 pandemic at The Heritage Foundation on Thursday, November 10, 2022. (Tom Williams/CQ-Roll Call, Inc via Getty Images)Health

    As COVID ‘contrarians’ take power, experts warn we’re even less prepared for the next pandemic

    By Arthur Allen and KFF Health News
  • An Ozempic (semaglutide) injection pen is seen on a kitchen table.Health

    How Denmark got homegrown giant Novo Nordisk to lower Ozempic prices

    By Arthur Allen and KFF Health News
  • Close-up of senior black woman sorting weekly medication. Member of a black middle class America family.Aging Well

    Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers

    By Arthur Allen and KFF Health News
  • Close-up of female pharmacist arranging drugs on rack. Confident owner is at pharmacy. She is working in medical store.Finance

    Biden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores

    By Arthur Allen and KFF Health News
  • STRAFFAN, IRELAND – APRIL 25: Tim Walbert, Chairman, President and CEO of Horizon Therapeutics attends the Horizon Irish Open announcement at The K Club on April 25, 2022 in Straffan, Ireland. The K Club to host Horizon Irish Open in 2023, 2025 and 2027. (Photo by Patrick Bolger/Getty Images)Health

    How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own

    By Arthur Allen and KFF Health News
  • A scientist works at the Pfizer vaccine research and development facility in Pearl River, New York, US, on Thursday, June 16, 2022. Pfizer Inc. emerged from the Covid-19 pandemic as the worlds most visible drugmaker, but its success has left investors impatient for an encore. Photographer: Amir Hamja/Bloomberg via Getty ImagesHealth

    Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune

    By Arthur Allen and Kaiser Health News
  • Elderly man holding his medicineHealth

    Inside the lobbying push to get Medicare to pay for a controversial Alzheimer’s drug

    By Arthur Allen and Kaiser Health News
  • A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at Coors Field in Denver, Colorado, U.S., on Saturday, Feb. 20, 2021. More than 1 million doses of Covid-19 vaccines have been administered to Coloradans to date as public health officials are nearing their goal of inoculating 70% of all people 70 and older, state representatives said Thursday. Photographer: Chet Strange/BloombergHealth

    With billions spent and ‘wartime’ declared, why are vaccines still in short supply?

    By Rachana Pradhan, Arthur Allen, and others
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.